Broad-spectrum antiviral effect of MoringaA-loaded exosomes against IAV by mediating the GCN5-TFEB-autolysosome pathway.

J Med Virol

Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi, Guizhou, China.

Published: September 2024

AI Article Synopsis

  • Influenza virus-induced pneumonia poses a significant health risk, and effective treatments are currently unavailable.
  • MoringaA (MA), derived from Moringa seeds, shows promise in inhibiting the influenza virus by activating a specific cellular pathway called the TFEB-autophagic lysosomal pathway.
  • The study developed MoringaA-encapsulated exosomes (MA-Exos) that successfully inhibited the virus and promoted autophagy in lung cells, while also revealing that the intervention down-regulates the GCN5 gene, which helps prevent inflammation-related damage.

Article Abstract

Influenza virus-induced viral pneumonia is a major threat to human health, and specific therapeutic agents for viral pneumonia are still lacking. MoringaA (MA) is an anti-influenza virus active compound isolated from Moringa seeds, which can inhibit influenza virus by activating the TFEB-autophagic lysosomal pathway in host cells. In this study, we obtained exosomes from M2-type macrophages and encapsulated and delivered MA (MA-Exos), and we investigated the efficacy of MA-Exos in antiviral and viral pneumonia in vivo and in vitro, respectively. In addition, we provided insights into the mechanism by which MA-Exos regulates TFEB-lysosomal autophagy by RNA sequencing. The MA-Exos showed broad-spectrum inhibition of IAV, and significant promotion of the autophagic lysosomal pathway. Meanwhile, we found that GCN5 gene and protein were significantly down-regulated in IAV-infected cells after MA-Exos intervention, indicating its blocking the acetylation of TFEB by GCN5. In addition, MA-Exos also significantly promoted autophagy in lung tissue cells of mice with viral pneumonia. MA-Exos can inhibit and clear influenza virus by mediating the TFEB-autophagy lysosomal pathway by a mechanism related to the down-regulation of histone acetyltransferase GCN5. Our study provides a strategy for targeting MA-Exos for the treatment of viral pneumonia from both antiviral and virus-induced inflammation inhibition pathways.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.29906DOI Listing

Publication Analysis

Top Keywords

viral pneumonia
20
lysosomal pathway
12
influenza virus
8
ma-exos
8
viral
5
pneumonia
5
broad-spectrum antiviral
4
antiviral moringaa-loaded
4
moringaa-loaded exosomes
4
exosomes iav
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!